The QQQ Options Strategy That Blew Away Buy & Hold

Video Description

➡️Join Income Academy Today! 45% OFF Thru 12/31! ⬅️ ------------------------------------------------------------------------ Go from Average Joe to Income Investor: https://www.skool.com/incomeacademy/about?ref=464064fbb8a647279816af4122ecc488 ------------------------------------------------------------------------ This communication/content is for informational purposes only and is not intended as personalized investment advice, tax, accounting or legal advice, as an offer or solicitation of an offer to buy or sell, or as an endorsement of any company, security, fund, or other securities or non-securities offering. This communication should not be relied upon for purposes of transacting in securities or other investment vehicles. ------------------------------------------------------------------------ Buying QQQ LEAPS can give you leveraged upside to Nasdaq 100 growth with less capital than owning shares, but it absolutely does not “beat” buy‑and‑hold QQQ in all environments and carries meaningful path and timing risk. ​ ​ What LEAPS on QQQ actually give you Long‑dated calls (LEAPS) let you control 100 shares of QQQ for a fraction of the cost of buying the stock outright, freeing capital for other uses or risk management. ​ Time decay is relatively slow when you’re 1+ year out, so most of your P/L is driven by QQQ’s directional move and changes in implied volatility rather than daily theta bleed. ​ ​ Deep‑ITM or ~0.7–0.8 delta LEAPS behave mostly like stock on the upside, but your downside is capped at the premium paid instead of the full value of 100 shares. ​ ​ Why LEAPS can be attractive vs. stock Capital efficiency: Example from one QQQ LEAPS income article: roughly controlling 100 shares might cost about 25–30% of the cash required to buy 100 QQQ shares, allowing you to control more notional per dollar or keep cash in T‑bills. ​ Asymmetric downside: If QQQ crashes, your max loss is the premium, whereas a stock holder keeps losing as QQQ trends toward zero; as price drops, call delta falls and losses slow relative to stock. ​ Income overlays: Some traders pair long QQQ LEAPS with short covered calls (poor man’s covered call) to generate weekly or monthly income that can materially boost effective returns when QQQ grinds higher. ​ Why LEAPS often don’t beat buy‑and‑hold QQQ Expiration risk and path dependence: If QQQ chops or grinds up slowly, theta and IV crush can leave your LEAPS underperforming stock even if QQQ is higher by expiration or roll date. ​ ​ Need for timing skill: Backtests of QQQ LEAPS “buy on pullback” or 12‑month LEAPS strategies show strong results in bull phases but notable drawdowns or multiple losing years in bear phases like 2022. ​ ​ Q long‑term edge: QQQ itself has compounded at mid‑teens annualized over long windows (10‑year returns 100% total), and you capture that without needing to roll, manage Greeks, or forecast volatility. ​ Structural advantages of just owning QQQ No decay clock: QQQ has no expiration; LEAPS require periodic rolls, which introduce slippage, bid/ask friction, and the risk of rolling at unfavorable volatility or price levels. ​ ​ Full participation & dividends: Shareholders get all price appreciation plus QQQ’s modest yield, while call holders forgo dividends and can lose upside if their contracts are struck too far OTM or get exercised around ex‑div. ​ Behavioral simplicity: Buy‑and‑hold QQQ is mechanically simple and less likely to trigger “top‑up after losses” behavior that some LEAPS strategies require in multi‑year drawdowns. ​ ​ When QQQ LEAPS might be wise for growth You have a strong, thesis‑driven bullish view on the Nasdaq 100 over a defined 1–3 year window and are comfortable risking a known premium for leveraged upside. ​ ​ You value capital efficiency (e.g., want to keep cash in short‑term Treasuries or for other strategies) more than owning the underlying outright. ​ You are systematic about entries, roll rules (e.g., always 12 months DTE and roll at 60–90 DTE), and position sizing, treating LEAPS as a high‑beta sleeve rather than a full replacement for QQQ. ​